BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29624151)

  • 21. Impact of timing of radiation therapy on outcomes in atypical meningioma: A clinical audit.
    Pant S; Tonse R; Kannan S; Moiyadi A; Shetty P; Epari S; Sahay A; Sastri GJ; Jalali R; Gupta T
    Pract Radiat Oncol; 2018; 8(5):e275-e284. PubMed ID: 29861352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
    Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
    Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Necrosis and Brain Invasion Predict Radio-Resistance and Tumor Recurrence in Atypical Meningioma: A Retrospective Cohort Study.
    Garcia-Segura ME; Erickson AW; Jairath R; Munoz DG; Das S
    Neurosurgery; 2020 Dec; 88(1):E42-E48. PubMed ID: 32818240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
    Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
    Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
    Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
    J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
    Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
    Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major complications from radiotherapy following treatment for atypical meningiomas.
    Dawley T; Rana Z; Abou-Al-Shaar H; Goenka A; Schulder M
    Neurosurg Focus; 2019 Jun; 46(6):E5. PubMed ID: 31153147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors associated with postoperative recurrence in atypical intracranial meningioma: analysis of 263 cases at a single neurosurgical centre.
    Wang F; Xu D; Liu Y; Lin Y; Wei Q; Gao Q; Lei S; Guo F
    Acta Neurochir (Wien); 2019 Dec; 161(12):2563-2570. PubMed ID: 31641861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of radiotherapy following gross-total resection of atypical meningiomas.
    Komotar RJ; Iorgulescu JB; Raper DM; Holland EC; Beal K; Bilsky MH; Brennan CW; Tabar V; Sherman JH; Yamada Y; Gutin PH
    J Neurosurg; 2012 Oct; 117(4):679-86. PubMed ID: 22920955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation Therapy for Residual or Recurrent Atypical Meningioma: The Effects of Modality, Timing, and Tumor Pathology on Long-Term Outcomes.
    Sun SQ; Cai C; Murphy RK; DeWees T; Dacey RG; Grubb RL; Rich KM; Zipfel GJ; Dowling JL; Leuthardt EC; Simpson JR; Robinson CG; Chicoine MR; Perrin RJ; Huang J; Kim AH
    Neurosurgery; 2016 Jul; 79(1):23-32. PubMed ID: 26645969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes.
    Marciscano AE; Stemmer-Rachamimov AO; Niemierko A; Larvie M; Curry WT; Barker FG; Martuza RL; McGuone D; Oh KS; Loeffler JS; Shih HA
    J Neurosurg; 2016 Jan; 124(1):106-14. PubMed ID: 26274991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival and Prognostic Predictors of Anaplastic Meningiomas.
    Masalha W; Heiland DH; Delev D; Fennell JT; Franco P; Scheiwe C; Mercas BI; Mader I; Schnell O; Grauvogel J
    World Neurosurg; 2019 Nov; 131():e321-e328. PubMed ID: 31356972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival Benefit of Adjuvant Radiotherapy in Elderly Patients with WHO Grade III Meningioma.
    Zhou H; Bai HX; Chan L; Zhang PJ; Karakousis G; Huang R; Xiao B; Yang L
    World Neurosurg; 2019 Nov; 131():e303-e311. PubMed ID: 31356979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
    McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; QuiƱones-Hinojosa AR
    J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival and Recurrence Outcomes Following Adjuvant Radiotherapy for Grade 2 Intracranial Meningiomas: 13-Year Experience in a Tertiary-Care Center.
    Rebchuk AD; Alam A; Hounjet CD; Chaharyn BM; Gooderham PA; Yip S; Ma RMK; Nichol A; Makarenko S
    World Neurosurg; 2022 May; 161():e748-e756. PubMed ID: 35240308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
    Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
    Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should adjuvant radiotherapy be used in atypical meningioma (WHO grade 2) following gross total resection? A systematic review and Meta-analysis.
    Wujanto C; Chan TY; Soon YY; Vellayappan B
    Acta Oncol; 2022 Sep; 61(9):1075-1083. PubMed ID: 36052871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
    Soni P; Davison MA; Shao J; Momin A; Lopez D; Angelov L; Barnett GH; Lee JH; Mohammadi AM; Kshettry VR; Recinos PF
    J Neurooncol; 2021 Jan; 151(2):173-179. PubMed ID: 33205354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.